Latest Tax Rebates News

Ardea Resources reports significant progress on its Kalgoorlie Nickel Project, completing key drilling and metallurgical work while securing $4.6 million in strategic funding from Sumitomo Metal Mining. The company remains well-funded as its joint venture partners advance the Definitive Feasibility Study.

Anax Metals has raised $3.3 million through convertible notes to push forward its Whim Creek copper-zinc project in Western Australia, while resolving a recent arbitration with its cornerstone investor Mineral Development Partners.

Artrya has launched its AI-powered Salix Coronary Anatomy platform in the U.S. and submitted its Coronary Plaque module for FDA clearance, marking a key step in its commercial expansion. A new five-year contract with Tanner Health signals the start of U.S. revenues.

Adslot Ltd has activated its StoreFront digital advertising platform across multiple international markets, driving $148.9 million in total transaction value for FY25 amid significant cost savings and a growing sales pipeline.

Zelira Therapeutics has locked in a $650,000 loan facility secured against its anticipated FY25 R&D tax rebate, aiming to accelerate its HOPE SPV clinical trial and strengthen working capital.

Great Dirt Resources has secured a significant exploration licence in the Pilbara lithium province and bolstered its finances with a $335,000 R&D tax rebate, setting the stage for accelerated exploration activities.

South Harz Potash Limited has launched a two-tranche placement and a rights issue to raise over A$3 million, aiming to accelerate development of its German potash assets amid mixed funding prospects.

Acrux Limited has secured a further $0.46 million advance on its FY25 R&D Tax Incentive, bringing total advances to $2.19 million and supporting its pharmaceutical product development and working capital needs.

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.

South Harz Potash Limited has launched a two-tranche equity raising to secure up to A$3.11 million, aiming to advance its dual-asset strategy and strengthen its position in the European potash market.

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Algorae Pharmaceuticals has secured a significant A$318,771 R&D tax incentive rebate from the Australian Taxation Office, providing a non-dilutive cash injection to advance its AI-driven drug discovery programs.